Program Director/Principal Investigator (Last, First, Middle): Joseph, JIN G. After a decade of remarkable research growth and institutional investment. Children's National Medical Center (CNMC) builds on significant strategic recruitments, reorganizations, and collaborations required to create the transformative capabilities of the Clinical and Translational Science Institute at Children's National (CTSI-CN). It has done so in partnership with its academic affiliate, the George Washington University. The specific objectives of our application are to: 1) Provide state-of-the-art, flexible resources required by CTR investigators; 2) Promote multidisciplinary clinical and translational research (CTR);3) Strengthen CTR education and training for diverse trainees at all stages of career development;4) Promote demographic diversity and address health disparities;5) Incorporate effective and sustained collaboration with community partners;6) Assure efficiency of CTR from conceptualization through dissemination;and 7) Establish bi-directional collaborations with the CTSA network. The CTSI-CN has innovative features including: a child health focus, especially emphasizing health disparities and childhood antecedents of adult diseases;our relationship with a national network of 1200 community health centers, and in Tl strengths in rare diseases and neurodevelopmental disabilities. We have combined certain related CTSA components to provide more closely integrated, investigator-focused capabilities. Biomedical Informatics (Bl): provides the backbone informatics support to all CTSI-CN components. Research Education, Training and Career Development (RETCD) integrates, supports, and expands CTR education and training so that it is available from high school through mid-career. A new degree program (MS in CTR) and a certificate program are complemented by diverse educational opportunities for faculty, trainees, and staff at all levels of experience. Specialized programs are available for mid-level faculty to promote their career advancement and mentoring capabilities, and for underrepresented minority undergraduates potentially interested in a career in CTR. Community Engagement and Research/Health Policy (CER/HP) integrates traditional community engagement/research with nationally recognized health policy capabilities. Participant and Clinical Interactions Resources (PCIR) transforms our existing GCRC into a nimble and innovative resource that supports participant interactions at diverse locations including CNMC, outpatient facilities, GW, and the community. Pilot and Collaborative Translational and Clinical Studies: supports transfomnative ideas by investigators at all career levels. Novel Clinical and Translational Methodologies (NCTM) identifies needs and gaps and supports development of innovative methodologies, especially to support TTR cores. Research Design. Epidemiology. Biostatistics, and Clinical Research Ethics/Regulatory Knowledge and Support (DBE/RKS): provides integrated, investigator-focused resources to assure the quality of research and the protection of human subjects at all stages of research. Translational Technologies and Resources (TTR) supports a diverse group of 15 core functions. Tracking and Evaluation (TE): CTSI-CN activities will be guided and modified by a thoughtful and detailed evaluation plan.
The CTSI-CN provides highly integrated, cost effective, investigator-focused resources designed to overcome obstacles to investigation, promote collaborative research, and be continuously monitored and evaluated to identify when further adaptation or modification is needed. Located in the nation's capital and serving a population of children and families disproportionately affected by health disparities, the CTSI-CN brings to bear unique resources in translating discovery to improved health, particularly in our most disadvantaged populations of children.
|Burga, Rachel A; Patel, Shabnum; Bollard, Catherine M et al. (2016) Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapy. Nanomedicine (Lond) 11:1759-67|
|Govindan, Rathinaswamy B; Al-Shargabi, Tareq; Massaro, An N et al. (2016) Baroreflex dysfunction in sick newborns makes heart rate an unreliable surrogate for blood pressure changes. Pediatr Res 79:929-33|
|Monaghan, Maureen; King, Megan McCormick; Alvarez, Vanessa et al. (2016) Changes in type 1 diabetes health indicators from high school to college. J Am Coll Health 64:157-61|
|Zachariah, Justin P; Aliku, Twalib; Scheel, Amy et al. (2016) Amino-terminal pro-brain natriuretic peptide in children with latent rheumatic heart disease. Ann Pediatr Cardiol 9:120-5|
|Nikbakht, Hamid; Panditharatna, Eshini; Mikael, Leonie G et al. (2016) Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma. Nat Commun 7:11185|
|Klugman, Darren; Berger, John T (2016) Echocardiography and Focused Cardiac Ultrasound. Pediatr Crit Care Med 17:S222-4|
|Patregnani, Jason; Klugman, Darren; Zurakowski, David et al. (2016) High on Aspirin Platelet Reactivity in Pediatric Patients Undergoing the Fontan Procedure. Circulation 134:1303-1305|
|Yadav, Kabir; Sarioglu, Efsun; Choi, Hyeong Ah et al. (2016) Automated Outcome Classification of Computed Tomography Imaging Reports for Pediatric Traumatic Brain Injury. Acad Emerg Med 23:171-8|
|Pancham, Krishna; Sami, Iman; Perez, Geovanny F et al. (2016) Human Metapneumovirus Infection is Associated with Severe Respiratory Disease in Preschool Children with History of Prematurity. Pediatr Neonatol 57:27-34|
|Ploutz, Michelle; Lu, Jimmy C; Scheel, Janet et al. (2016) Handheld echocardiographic screening for rheumatic heart disease by non-experts. Heart 102:35-9|
Showing the most recent 10 out of 38 publications